Atrion (ATRI) Upgraded to “Buy” at BidaskClub

BidaskClub upgraded shares of Atrion (NASDAQ:ATRI) from a hold rating to a buy rating in a research report report published on Thursday.

ATRI stock traded up $3.00 on Thursday, reaching $713.00. The company’s stock had a trading volume of 6,000 shares, compared to its average volume of 7,907. Atrion has a 52 week low of $516.85 and a 52 week high of $718.11. The firm has a market capitalization of $1.29 billion, a price-to-earnings ratio of 38.16 and a beta of 0.56.

Atrion (NASDAQ:ATRI) last issued its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported $4.70 earnings per share (EPS) for the quarter. Atrion had a return on equity of 17.99% and a net margin of 22.57%. The business had revenue of $38.85 million during the quarter.

Hedge funds have recently modified their holdings of the stock. BTIM Corp. bought a new position in Atrion during the 2nd quarter valued at $8,700,000. Cornerstone Wealth Management LLC boosted its stake in Atrion by 21.6% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 65,995 shares of the medical instruments supplier’s stock valued at $100,000 after purchasing an additional 11,743 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Atrion by 11.2% during the 2nd quarter. Renaissance Technologies LLC now owns 69,500 shares of the medical instruments supplier’s stock valued at $41,658,000 after purchasing an additional 7,000 shares in the last quarter. BlackRock Inc. boosted its stake in Atrion by 6.5% during the 2nd quarter. BlackRock Inc. now owns 99,503 shares of the medical instruments supplier’s stock valued at $59,642,000 after purchasing an additional 6,095 shares in the last quarter. Finally, Assenagon Asset Management S.A. bought a new position in Atrion during the 3rd quarter valued at $4,172,000. 62.30% of the stock is owned by institutional investors and hedge funds.

About Atrion

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Read More: Momentum Indicator: Relative Strength Index

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply